For example, mutations at codon 273 in astrocytoma are associated with significantly longer overall survival (OS) and increased chemosensitivity compared to wild-type TP53, whereas in oligodendroglioma, TP53 mutations correlate with shorter OS (40). The gene discussed is TP53; the disease is astrocytoma (excluding glioblastoma).